Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia

Abstract

HCT using this RIC approach was well tolerated and successful in achieving donor engraftment and early immune reconstitution with good quality of life free of immune suppression. Children with SAA can be successfully transplanted using alemtuzumab based conditioning.